Inhibitors of RSV replication of formula RI
including stereochemically isomeric forms, and salts or solvates thereof, wherein R
22
, W, Q, V, Z p, s, and Het have the meaning as defined herein.
The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other RSV inhibitors, in RSV therapy.